Post by luxetvox on Apr 3, 2024 18:18:31 GMT
....cause I sent it to him
Do you have even a basic understanding of what it takes to get a stock moving to the upside?
1. Sure, there is the P related to E. But since Opko has no E, this path is closed at the moment.
2. Yes, there are instances of locked up value. This is relevant to examples like Nelson Pelts's proxy fight at Disney, but is entirely irrelevant with Opko. Sorry, but, the numbers in your 'analysis' on Yahoo are, well they're made up. Put another way, what do you think Mike Petusky of Barrington, a CFA whose expertise is rigorous equity analysis, is missing from the equation you are proposing for the 'value' of Opko.
3. Institutional sponsorship of the story. As an example, today my firm put out a 50% PT increase on a pre-revenue biotech. I don't want to mention the name but here's some info....$250mm mkt cap, entire BOD are either MD or Ph.D, or both, with LOTS of public company experience. 52 million shares outstanding, among top 10 holders are SEVEN Healthcare focused funds.
Unless and until you understand the reality that there are ZERO Healthcare focused investors in Opko, then your 'value' analysis, and other Yahoo small frys touting their Opko trading prowess, are just quixotic distractions. The company needs to find some deep pocketed buyers. Would you trust Frost to make a cogent presentation in front of Deerfield Management? Ummmmm, I know I wouldn't. Elias is the guy for that; but as he told Bill on our call, he has to do a LOT of work ahead before he can tell a convincing story. That work is not just tactical: keeping expenses low so that high margin revenue from Ngenla doesn't fall into Phil's Fire Pit. But it's multi-stage strategic: monetizing most, and perhaps all, of the non-pharma businesses, reducing the share count BIGLY, and doing more deals (partnerships and/or royalty arrangements) to eliminate the idiotic debt on the books.